Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 31;13(1):157.
doi: 10.1186/s13756-024-01513-2.

Screening sites for detection of carbapenemase-producers- a retrospective cohort study

Isabelle Vock  1 , Silvio Ragozzino  1 , Pascal Urwyler  1 , Michelle Baumann  1 , Gioele Capoferri  1 , Peter M Keller  2 , Sarah Tschudin-Sutter  3   4
Affiliations

Screening sites for detection of carbapenemase-producers- a retrospective cohort study

Isabelle Vock et al. Antimicrob Resist Infect Control. .

Abstract

While screening the rectal site and urine may be appropriate for detection of carbapenemase-producing Enterobacterales, respiratory samples, throat and wound swabs may increase the sensitivity of screening protocols when aiming to detect colonization with carbapenemase-producing non-fermenting bacteria. Our results support the need for tailoring screening recommendations according to the bacterial species targeted.

Keywords: Carbapenemase-producing Enterobacterales; Carbapenemase-producing bacteria; Carbapenemases; Non-fermenting bacteria; Screening.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the local ethics committee (Ethikkomission Nordwest- und Zentralschweiz (EKNZ), Project-ID 2019–01548). Competing interests: All authors declare, that they do not have competing interests. S. Tschudin-Sutter serves as editor of the journal Antimicrobial Resistance and Infection Control.

References

    1. Tomczyk S, Zanichelli V, Grayson ML, Twyman A, Abbas M, Pires D, et al. Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in healthcare facilities: a systematic review and reanalysis of quasi-experimental studies. Clin Infect Dis. 2019;68(5):873–84. - PMC - PubMed
    1. Bopp TC, Marchesi M, Zihlmann R, Sax H, Wolfensberger A. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad. Infect Control Hosp Epidemiol. 2023;44(8):1281–8. - PubMed
    1. Martischang R, Buetti N, Balmelli C, Saam M, Widmer A, Harbarth S. Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions. Antimicrob Resist Infect Control. 2019;8:37. - PMC - PubMed
    1. Hinic V, Amrein I, Stammler S, Heckendorn J, Meinel D, Frei R, et al. Comparison of two rapid biochemical tests and four chromogenic selective media for detection of carbapenemase-producing gram-negative bacteria. J Microbiol Methods. 2017;135:66–8. - PubMed
    1. Vock I, Aguilar-Bultet L, Goldenberger D, Ragozzino S, Kuster S, Tschudin-Sutter S. Epidemiology of patients harboring carbapenemase-producing bacteria and comparison with patients with detection of extended-spectrum beta-lactamase-producing Enterobacterales-A retrospective cohort study. Infect Control Hosp Epidemiol. 2023;44(12):1959–65. - PMC - PubMed

LinkOut - more resources